IVF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
INVO Fertility Inc (IVF) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite a positive pre-market price change, the technical indicators are bearish, and there is no significant trading momentum or positive news catalysts. While the company's revenue and net income have shown improvement, the EPS has significantly dropped, and the stock lacks strong support from analysts or trading signals. For a long-term investor, it may be better to wait for clearer signs of growth or stability before investing.
The technical indicators show a bearish trend with moving averages (SMA_200 > SMA_20 > SMA_5). The RSI is neutral at 24.046, and the MACD histogram is slightly positive but contracting. The stock is trading near its support level (S1: 0.823), with resistance at R1: 0.938.
Revenue increased by 22.60% YoY in Q3 2025, and net income improved by 62.18% YoY. Gross margin also increased significantly by 87.56%. Analyst Maxim upgraded the stock to 'Buy' with a $4 price target.
The stock has bearish technical indicators and lacks recent positive news or trading momentum. Hedge funds and insiders are neutral, with no significant trading trends.
In Q3 2025, revenue increased to $1,757,094 (up 22.60% YoY), and net income improved to -$2,644,625 (up 62.18% YoY). However, EPS dropped to -6.14 (down -94.92% YoY). Gross margin increased to 28.04% (up 87.56% YoY).
Maxim upgraded the stock to 'Buy' from 'Hold' with a $4 price target on February 10, 2026.
